18000 doses a day in anz, page-41

Pigs

The numbers don't fall out too different. You still have about a half million animals or a little more per year to treat in Australia and New Zealand. That will result in retail sales of about $15,000,000 per year, expecting about $1,500,000 to flow to Phosphagenics or about 0.15 cents per (potentially) diluted share. That would potentially add 2 to 3 cents per share to the share price, all things being equal.

What makes this a real money maker going forward is the world market, which ought to be 15 to 20 times larger, and if the results are anything like what's touted on the Mastitis Australia website, this will be a very widely accepted treatment for all the reasons already laid out.